|Articles|July 12, 2022
Clariness Extends Contract With Klinische Forschung Berlin GbR
More studies added to Clariness' patient recruitment platform.
Advertisement
Clariness has extended its contract with Klinische Forschung Berlin GbR (Klifo Berlin GbR) through listing additional studies on its platform.
Klifo Berlin GbR listed several studies on Clariness’ patient-friendly study platform, ClinLife, in March 2021. Since then, more than 75 patients have been enrolled and randomized.
Read more about this partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
4
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
